Dr. Nayan Patel

IVs were short-lived.

The liposome, I could not figure out why it was not working.

So I said, there has to be different technology.

And every technology in the world existed that never enters the peptides, that the glutathione is a tripeptide.

There's no technology in the world that existed at that point that can actually help peptides get into your system.

And to me, I said, okay, and why peptides?

Why am I dealing with peptides?

Because in the early 2000s, I was actually making all the hormones.

Now we call them peptides today, but at that time, we were making all the hormones in the pharmacy because I had doctors come in and say, hey, can you make me all these hormones for me?

I said, well, some of the hormones I can make, some of the hormones I cannot make.

Right.

So we're looking at all the hormones, estrogen, progesterone, testosterone, DHEA, all those things were easy to make because those are all good hormones, so they're easy to make.

And then they go, oh, how about some of the pituitary and hypothalamic hormones, like ACTA, GDRH, LHRH, corticorelin, all those things.

I said, well...

those are a bit harder to make, you know.

And so I was working with a couple of researchers trying to figure out, I said, hey, how about we just do a research-based modules where you get some approvals and we'll do some research projects together and see if that works out.

And what we found out is that those peptides or the hormones

The needs are very, very small if it's done correctly.

And so that's where my learnings came in first.

I said, the glutathione, if it's done correctly, our needs are actually very small.